Corporate Board Profile
Tech Score: 22/100
4 mention(s) identify DANIEL R. OMSTEAD, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| abrdn Healthcare Investors | 2018-04-18 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He was President and CEO of biotech companies and serves on boards of portfolio companies. | Holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry, with experience in biotech and pharmaceutical industries, including leadership roles in development stage biotech companies. His technical degrees and scientific background indicate capability to write programs or have software-related skills. |
| abrdn Healthcare Investors | 2021-04-13 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University... Prior to joining the Adviser, Dr. Omstead was President and CEO of Reprogenesis, Inc., a private development stage biotech company. | Dr. Omstead holds Ph.D. and Master's degrees in Chemical Engineering and Applied Chemistry and has experience in biotech companies, indicating technical and scientific expertise that likely includes programming or related skills. |
| abrdn Healthcare Investors | 2022-04-12 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. | Dr. Omstead holds Ph.D. and Master's degrees in Chemical Engineering and Applied Chemistry, indicating strong technical and scientific expertise, though no direct programming experience is mentioned. |
| abrdn Healthcare Investors | 2023-04-11 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry and has experience in biotech and pharmaceutical industries, indicating a strong technical background that likely includes programming skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2005-05-10 | President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. |
| 2006-05-08 | President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; Director (since 2003) of Concentric Medical, Inc.; President and Chief Executive Officer (from 1998-2000) of Reprogenesis, Inc. |
| 2007-05-10 | Daniel R. Omstead, Ph.D. (53), President of HQH and of HQL (since 2001); Trustee of HQH and of HQL (since 2003), President, Chief Executive Officer and Managing Member (since July 2002) of Hambrecht & Quist Capital Management LLC; President and Chief Executive Officer (2001-June 2002) and Managing Director (2000-June 2002) of Hambrecht & Quist Capital Management, Inc.; Director (since 2003) of Concentric Medical, Inc.; and Magellan Biosciences (since 2006). |
| 2008-05-05 | Daniel R. Omstead, Ph.D. President of HQH and HQL (since 2001); Trustee of HQH and HQL (since 2003); President, Chief Executive Officer and Managing Member of Hambrecht & Quist Capital Management LLC; Director of Magellan Biosciences, Inc. (since 2006). |
| 2009-05-01 | President, Chief Executive Officer and Managing Member of Hambrecht & Quist Capital Management LLC (since 2002); Director of Magellan Biosciences, Inc. (since 2006); Director of Elemé Medical, Inc. (since 2008); Director of Concentric Medical, Inc. (2003-2007; 2008-present). |
| 2010-04-27 | Trustee, HQH and HQL (since 2003); President, HQH and HQL (since 2001); President, Chief Executive Officer and Managing Member, Hambrecht & Quist Capital Management LLC (since 2002); Director, Magellan Biosciences, Inc. (since 2006); Director, Elemé Medical, Inc. (since 2008); Director, Concentric Medical, Inc. (2003-2007; 2008-present); Director, Palyon Medical Corporation (since 2009). |
| 2011-06-08 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2012-04-30 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2013-04-25 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He was President and CEO of biotech companies and is President and CEO of Tekla Capital Management LLC. |
| 2014-04-30 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He has been President and CEO of biotech companies and is President and CEO of Tekla Capital Management LLC. |
| 2015-04-20 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He is President and CEO of Tekla Capital Management LLC and has biotech industry experience. |
| 2016-04-18 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2017-04-18 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He was President and CEO of biotech companies and is President and CEO of Tekla Capital Management LLC. |
| 2018-04-18 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. He was President and CEO of biotech companies and serves on boards of portfolio companies. |
| 2020-04-14 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University... Dr. Omstead provides each Fund with insights into both pharmaceutical and biotech companies. |
| 2021-04-13 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University... Prior to joining the Adviser, Dr. Omstead was President and CEO of Reprogenesis, Inc., a private development stage biotech company. |
| 2022-04-12 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
| 2023-04-11 | Dr. Omstead holds Ph.D. and Master's Degrees in Chemical Engineering and Applied Chemistry from Columbia University and a B.S. degree in Civil Engineering from Lehigh University. |
Data sourced from SEC filings. Last updated: 2025-07-01